A detailed history of First Horizon Advisors, Inc. transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 618 shares of TNDM stock, worth $20,591. This represents 0.0% of its overall portfolio holdings.

Number of Shares
618
Previous 544 13.6%
Holding current value
$20,591
Previous $19,000 26.32%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

BUY
$30.43 - $53.43 $2,251 - $3,953
74 Added 13.6%
618 $24,000
Q1 2024

Apr 26, 2024

BUY
$22.09 - $35.41 $684 - $1,097
31 Added 6.04%
544 $19,000
Q4 2023

Feb 06, 2024

BUY
$14.28 - $31.03 $4,483 - $9,743
314 Added 157.79%
513 $15,000
Q3 2023

Oct 27, 2023

BUY
$19.33 - $36.22 $3,846 - $7,207
199 New
199 $4,000
Q4 2022

Feb 10, 2023

SELL
$35.49 - $56.15 $1,419 - $2,246
-40 Reduced 81.63%
9 $0
Q3 2022

Nov 09, 2022

SELL
$43.76 - $68.97 $1,706 - $2,689
-39 Reduced 44.32%
49 $1,000
Q2 2022

Aug 02, 2022

SELL
$53.22 - $123.09 $1,277 - $2,954
-24 Reduced 21.43%
88 $5,000
Q1 2022

May 10, 2022

BUY
$101.89 - $150.09 $101 - $150
1 Added 0.9%
112 $13,000
Q3 2021

Nov 09, 2021

BUY
$93.51 - $129.4 $2,711 - $3,752
29 Added 35.37%
111 $13,000
Q2 2021

Aug 09, 2021

BUY
$77.0 - $100.19 $1,309 - $1,703
17 Added 26.15%
82 $7,000
Q1 2021

May 11, 2021

SELL
$81.28 - $104.34 $1,544 - $1,982
-19 Reduced 22.62%
65 $5,000
Q4 2020

Feb 11, 2021

SELL
$86.4 - $121.75 $950 - $1,339
-11 Reduced 11.58%
84 $8,000
Q3 2020

Nov 12, 2020

BUY
$95.43 - $116.09 $572 - $696
6 Added 6.74%
95 $10,000
Q4 2019

Jan 07, 2020

SELL
$53.13 - $71.19 $2,072 - $2,776
-39 Reduced 30.47%
89 $5,000
Q3 2019

Oct 23, 2019

BUY
$57.11 - $73.3 $7,310 - $9,382
128 New
128 $7,000

Others Institutions Holding TNDM

About TANDEM DIABETES CARE INC


  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $2.14B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track First Horizon Advisors, Inc. Portfolio

Follow First Horizon Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.